Connect to your MyAIJA account to discover who from your network is attending this event.
Join AIJA’s Antitrust and Life Sciences Commissions for an up-to-date academic programme focusing on pharma regulations and state support in times of COVID-19. A welcome reception will kick off the online programme and introduce you to the warmth and welcoming spirit of the AIJA community - just virtually this time.
The seminar will then run two webinars using Zoom on Friday, 12 June:
Governmental and regulatory reactions to reduce shortages of supply and price explosions
The need for medical products, medical devices, pharmaceuticals and protective equipment has never been as urgent as now. Governments need to secure the supply of affordable drugs and medical devices. The need for joint actions and cooperation in the industry seems vital to fight the outbreak. The healthcare sector relies on companies with high and sometimes even increased market power. Even so, the boarders are shut down, and medical products, devices and equipment are put under export restrictions while the barriers to trade are increased. During this webinar we will take the opportunity to reflect upon the present governmental and regulatory reactions to actual and potential shortages of supply, price explosions and cooperation among competitors.
State aid and governmental support
The rescue packages launched by governments for companies which are at loss during this health crisis are historically immense. During this webinar we will take the opportunity to reflect upon the variations of governmental actions and state aid in various jurisdictions. We will also discuss the legal basis for such measures and how it will affect the market.
The webinar is open to everyone.
AIJA members can register for free.
Please find the link to access the webinar in the confirmation email following your registration.
Antitrust and healthcare webinar: Pharma regulations and state support in times of COVID-19
Virtual welcome reception
The need for medical products, medical devices, pharmaceuticals and protective equipment has never been as urgent as now. Governments need to secure the supply of affordable drugs and medical devices. The need for joint actions and cooperation in the industry seems vital to fight the outbreak and the healthcare sector relies on companies with high and sometimes even increased market power. Even so, the boarders are shut down, medical products, devices and equipment are put under export restrictions and the barriers to trade are increased.
During this session we will reflect upon regulatory and antitrust related legal issues linked to the present COVID-19 situation. We will base our presentation on a fictive case taking place in the “AIJA state” to illustrate various scenarios.
The AIJA state in times of COVID-19:
The AIJA state is firmly in the grip of the COVID-19 pandemic. Due to the unexpected impact of the virus, there is quickly a shortage of various goods. The most important one is the shortage of face masks which are a key element to protect the population against infection and to stem the spread of the virus. To tackle this issue, the state has implemented various measures such as relaxing the regulatory requirements for the manufacture and distribution of masks.
As a consequence of the AIJA relaxation of regulatory requirements, masks are being produced not only by standard manufacturers of medical devices and protective equipment but also by textile manufacturers (amongst many other).
Furthermore, the masks are now being sold in the supermarkets directly to consumers whereas in the past, they were only available in pharmacies and healthcare services. This change led to new collaborations between industries and new distribution systems.
In order to optimize the production and distribution of the masks, the manufacturing companies Fudakowska and Barré came to an agreement: Fudakowska will distribute its masks exclusively to consumers through its own web shop and supermarkets. Barré, on the other hand, will limit itself to selling its masks directly to qualified healthcare service providers such as hospitals and GPs. Costa learning about this agreement through a whistle-blower files a complaint against Fudakowska and Barré in the AIJA state.
The second main measure implemented by the AIJA state is export restrictions. However, these restrictions have also been implemented by other states. This is why, in order to secure supply for its own population, the APC state is holding up in transit an important shipment from Carioca.
Siri Mårtensson Hjälmberg, Morris Law
Sofia Falkner, Hammarskiöld & Co
Janine Reudt-Demont, Niederer Kraft Frey
Marek Holka, Cechova & Partners
Michel Alexander, Smith & Williamson LLP
The rescue packages launched by the governments for the companies that suffers great loss during this health crisis are historically immense. During this webinar session we will take the opportunity to reflect upon the variations of governmental actions and state aid in various jurisdictions and also discuss the legal basis for such measures and how it will affect the market.
Johanna Svantesson, DLA Piper
Andrea Pomona, Debevoise & Plimpton LLP
Krzysztof Pawlak, Schoenherr Stangl sp.k.
Ruben Masar, VISCHER Ltd.
Fees & General InfoThere are currently no registration fees available.
General terms and conditions
By registering you have to accept the general terms and conditions and accept that your registration is considered binding immediately, but participation to the event is possible only after full payment of the registration fee.
Please note that any arrangements related to the participation of the participant in an AIJA event, including but not limited to booking or cancellation of accommodation or flights, as well as respecting the cancellation deadlines indicated in the general terms and conditions, are the sole responsibility of the participant. AIJA shall not be held liable for any expenses the participant may suffer as the result of participant’s failure to comply with his/her obligations.
It is recommended for each participant to purchase a cancellation and travel insurance.
Please note that in-house counsel registrations are subject to review and confirmation by AIJA. AIJA considers in-house counsel professionals who hold a university degree in law allowing access to a bar association and practicing law as an in-house counsel in private, public, or non-profit companies, institutions or organisations. Please note that in-house counsel who are at the same time active as fee-earning lawyers or consultants are not eligible to the discounted in-house counsel fee.
Please read the general terms and conditions applicable for AIJA events.
Become a sponsor
Partnership with AIJA as a sponsor provides the best networking opportunities in a relaxed business
If you have any questions, contact us on ‘Become a sponsor’ and check for more opportunities.
The personal data that you communicate to us shall be processed by the Iternational Association Of Young Lawyers (AIJA), with its registered office at Avenue de Tervueren 231, 1150 Brussels, Belgium (Tel: +32 2 347 33 34 - email@example.com), in accordance with Act No. 78-17 of January 6, 1978 relating to data, files and freedoms and Regulation No. 2016/679 on data protection, as of its entry into force on May 25, 2018.
Your data will be managed by AIJA's General Services, Events and Accounts Section:
- For the purpose of administering your registration for the event and your on-site access to the event;
- In order to pay for the selected services - your bank details will be deleted after receipt of your payment;
- In order to communicate information messages from AIJA.
To the extent necessary for the execution of their respective tasks, our subcontractors in charge of our seminar organisation, our IT infrastructure, our management, the production and maintenance of our website and extranet, are likely to gain access to your data from time to time. Their servers are located in the European Union.
Data relating to your participation in the event shall be stored for a period of 10 years. We are obliged to archive billing data until the end of the period required for our tax and accounting obligations, i.e. for 7 full tax years.
We shall store your contact information to keep you informed until you ask us to stop. You have the right to access your data and have it corrected if necessary.